DocSym
β
Searchsearch
Search
(E05.0) Thyrotoxicosis with diffuse goitre
More details coming soon
2 591 037 in individuals diagnosis thyrotoxicosis with diffuse goitre confirmed
22 528 deaths with diagnosis thyrotoxicosis with diffuse goitre
1% mortality rate associated with the disease thyrotoxicosis with diffuse goitre
Diagnosis thyrotoxicosis with diffuse goitre is diagnosed Women are 53.43% more likely than Men
603 273
Men receive the diagnosis thyrotoxicosis with diffuse goitre
4 791 (0.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 987 764
Women receive the diagnosis thyrotoxicosis with diffuse goitre
17 737 (0.9 %)Died from this diagnosis.
Risk Group for the Disease thyrotoxicosis with diffuse goitre - Men aged 55-59 and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features thyrotoxicosis with diffuse goitre
Absence or low individual and public risk
Thyrotoxicosis with diffuse goitre - what does this mean
Thyrotoxicosis with diffuse goitre is a condition caused by an overactive thyroid gland. it is characterized by an enlarged thyroid gland, hyperthyroidism, and excessive production of thyroid hormones. symptoms include fatigue, weight loss, nervousness, heat intolerance, and increased appetite. treatment options include antithyroid medications, radioactive iodine, and surgery.
What happens during the disease - thyrotoxicosis with diffuse goitre
Thyrotoxicosis with diffuse goitre is caused by an overproduction of thyroid hormones, usually due to an underlying condition such as graves' disease. the overproduction of thyroid hormones causes the thyroid gland to become enlarged and produces a diffuse goiter. as the levels of hormones increase, they can cause the body's metabolism to increase, leading to symptoms such as increased heart rate, weight loss, and heat intolerance.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Thyroid Function Tests (TFT)
- Thyroid Stimulating Hormone (TSH) Test
- Free T4 Test
- Free T3 Test
- Thyroid Antibody Tests
- Ultrasound of the Thyroid Gland
- Fine Needle Aspiration Biopsy (FNAB) of Thyroid
- Radioactive Iodine Uptake (RAIU) Test
- Complete Blood Count (CBC) Test
- Thyroid Peroxidase Antibodies (TPOAb) Test
- Thyroid-Stimulating Immunoglobulin (TSI) Test
- Thyroglobulin Antibody (TgAb) Test
Treatment and Medical Assistance
Main goal: To reduce the symptoms of thyrotoxicosis with diffuse goitre and return the patient to normal levels of thyroid hormones.
- Prescribe antithyroid medications (e.g. methimazole, propylthiouracil) to reduce thyroid hormone production.
- Prescribe beta-blockers (e.g. propranolol) to reduce symptoms such as palpitations and tremor.
- Prescribe steroids (e.g. prednisone) to reduce inflammation and swelling of the goitre.
- Administer radioactive iodine therapy to reduce thyroid hormone production.
- Perform thyroidectomy to remove the goitre and reduce thyroid hormone production.
- Monitor the patient's thyroid hormone levels with regular blood tests.
- Educate the patient on the symptoms of thyrotoxicosis and the importance of following the prescribed treatment plan.
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Thyrotoxicosis with diffuse goitre - Prevention
Thyrotoxicosis with diffuse goitre can be prevented by avoiding iodine-rich foods, getting regular check-ups to detect thyroid abnormalities, and receiving prompt treatment for any underlying thyroid disorders. additionally, avoiding exposure to radiation, such as x-rays or ct scans, can help reduce the risk of developing this condition.